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Introduction
Classical Hodgkin's lymphoma (cHL) is characterized by the presence of rare typical Hodgkin and Reed/Sternberg (HRS) cells, which represent the malignant cells of the tumor. The origin of these cells was controversially discussed until molecular studies showed their clonality and lymphoid derivation. In most cases, the malignant cells are derived from germinal center (GC) B cells, while in few cases the HRS cells show a T cell origin 1 . In B cell-derived cases, the occurrence of somatic deleterious ("crippling") mutations in the Ig genes of HRS cells in around 25% of the cHL cases has led to the idea that these cells are derived from preapoptotic GC B cells 1,2 . Unlike in cHL, the tumor cells in B cell non Hodgkin lymphoma (NHL) usually retain expression of typical B lineage markers. In addition, the malignant cells show a differentiation-linked phenotype, preserving the differentiation state of their normal counterparts during their oncogenic transformation 10,11 . This is not only the case for the expression of differentiation markers such as CD77 in Burkitt´s lymphoma or Bcl-6 in follicular lymphomas, which are normally expressed by GC B cells, but also for complex biological features as the ongoing hypermutation process and the retained follicular growth pattern in follicular lymphoma 12-14 . In order to comprehensively analyze to what extent the B lineage identity is affected in HRS cells, we compared large scale gene expression profiles from HL cell lines and normal B cell subsets regarding the expression of B lineage-associated genes. This analysis was performed using the SAGE technique and oligonucleotide DNA chip microarrays.
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Materials and Methods

Cell lines and culture
The HL cell lines used originate from patients with HL of the nodular sclerosis (L428 and HDLM2) or mixed cellularity subtype (KMH2 and L1236). HDLM2 is of T cell origin, the three other HL cell lines are of B cell origin 15-17 . All cell lines were grown in RPMI1640 with Glutamax-1 (Gibco), supplemented with 10% FCS and 100 U/ml penicillin/streptomycin at 37°C in an atmosphere containing 5% CO 2 .
Purification of human tonsillar centroblasts
Tonsils were taken from patients during routine tonsillectomy and mononucleated cells were purified by Ficoll density centrifugation. Centroblasts were stained consecutively with rat anti-CD77 (Immunotech), mouse anti-rat IgM (Serotec) and anti-mouse IgG1-Microbeads (Miltenyi) and enriched by magnetic cell separation (Miltenyi Biotec). The purity of CD77 + cells used for this study was higher than 95%. In total 2.5 x 10 8 centroblasts pooled from eight donors were used for the SAGE analysis.
Generation and analysis of SAGE expression data
SAGE, developed by Velculescue et al., generates a quantitative gene expression profile by high throughput sequencing 18 . The method is based on the principle that a nucleotide sequence of 10 bases length (a gene tag)
can mostly be assigned to a unique transcript, if its position in the mRNA molecule is known (downstream of the NlaIII restriction site nearest to the poly A sequence). Total RNA from centroblasts and the L1236 cell line was extracted with Trizol (Gibco). Poly-A + RNA was selected using the Oligotex mRNA kit (Qiagen) and 5 µg was used to synthesize ds-cDNA with the cDNA synthesis system (Gibco). SAGE was performed for both cell populations following the protocol version 1.0 d from Velculescue et al. (http//www.sagenet.org), with the following slight modifications. As described by Powell 19 , biotinylated primers were introduced in the ditag-PCR, and after the BsmF1 reaction magnetic beads coupled to streptavidin (Dynal) were used to purify the resulting ditags. Additionally, a heating step was included before gel purification of the concatemers 20 . SAGE profiles were generated by sequencing about 30,000 tags of both cell populations. The tag numbers given in text and tables are normalized to 30,000 and rounded up or down. The data were analyzed using the SAGE Software 2000, Version 4.12.
DNA chip microarrays (Affymetrix)
For personal use only. by on . www.bloodjournal.org From 5 RNA isolation and cDNA as well as cRNA synthesis were performed as described 21 . The cRNA was fragmented according to the Affymetrix protocol, and 15 µg of biotinylated cRNA was hybridised to U95A microarrays (Affymetrix), on which approximately 12,000 cDNAs are represented by oligonucleotide probes. In a supervised analysis, the four HL cell lines, as well as normal 20 samples corresponding to the normal B cell subsets (five samples each naive B cells, GC centrocytes, GC centroblasts and memory B cells, which were purified by magnetic cell separation) were defined as separate clusters, and the differentially expressed genes were identified by the Genes@Work software platform which is a gene expression analysis tool based on the pattern discovery algorithm SPLASH 22 .
The SPLASH software used for data evaluation is designed to identify genes consistently differentially expressed between groups of samples, so that we needed to use at least four HL cell lines and chose the ones 
.
Analysis for retained expression of B cell-specific genes
To search for genes specifically expressed in B cells we screened the PubMed database with search terms such as "B cell-specific expression", "B cell-restricted expression", "B cell marker human staining". The vast majority of these genes was identified as being downregulated in HL cell lines (Table 1, Figure 1 ).
Pax-5 analysis
Total RNA of HL cell lines was isolated with Trizol (Gibco) followed by cDNA synthesis using the Omniscript RT kit (Qiagen). RT-PCR for the complete coding sequence of Pax-5 was performed using aliquots 
Results
SAGE expression data reveal extensive downregulation of B lineage-specific genes
SAGE profiles consisting of about 30,000 tags were generated from tonsillar centroblasts, the putative nonmalignant counterpart of HRS cells, and the L1236 cell line with confirmed origin from the HRS cells of a cHL patient 15,16 . The SAGE software was used to identify genes that were deregulated by at least a factor of 5.0, and 280 distinct transcripts were found to be downregulated in the HRS cells according to this criterion. The analysis of genes upregulated in HRS cells will be published elsewhere. As we were interested in the downregulation of genes normally expressed in B cells, we analyzed the expression profiles for such genes, dividing them into three classes according to their expression pattern: B cell-, lymphoid-and hematopoieticspecific (defined here collectively as B lineage-specific genes). Intriguingly, 31 of the downregulated transcripts represented B lineage-specific genes (Table 1) . Among the genes showing two-to less than fivefold difference in gene expression level, downregulation of five additional B lineage markers was identified ( Table 1) .
Most of the B cell markers known to be downregulated in HRS cells (e.g. CD19, CD20, CD45, CD79a/b, OBF-1, Oct-2) 4,5,7,8 were also identified in this analysis. However, the majority of B lineage genes identified as downregulated in this study have not been described in cHL so far. In particular, we note lack of or reduced expression of many molecules important in BCR signaling, e.g. multiple protein tyrosine kinases (Syk, Lyn, Blk) or the BLNK protein, but also of important transcription factors such as Spi-B, Lyl-1 and A-myb ( Figure 1 , Table 1 ).
Expression data from microarrays reveal the loss of B lineage markers as a general feature of HL cell lines
The extensive downregulation of B lineage genes prompted us to verify and expand this finding by investigating gene expression profiles generated with microarrays (Affymetrix). In this analysis, four HL cell lines, L1236, L428, KMH2 and HDLM2, were defined as a cluster (see also Materials and Methods), and were compared to the main normal B cell populations (defined as the second cluster), namely five samples each of naive B cells, Most B lineage genes found to be downregulated in the SAGE profile were also identified as being downregulated in the microarray analysis (30 genes marked with (S) in Figure 1 ), providing a crossvalidation for both methods. However, within both analyses, some genes were identified which were not present in the other.
Detection of transcripts in the SAGE analysis may be restricted by the size of the profile (see legend of Table 1) , and polymorphisms or lack of NlaIII restriction sites in certain genes. On the oligonucleotide microarray, information of about 12,000 cDNAs is represented, which do not cover all transcripts expressed in a cell, and for some transcripts the oligonucleotides may be suboptimal. Differences between the two data sets may additionally be due to the different B cell populations the HL cell lines were compared with. For example, A-myb as a GCspecific transcription factor was not identified in the microarray analysis, since other normal B cell populations besides germinal center B cells do not express A-myb, so that it is not consistently expressed in normal B cells. 
Verification of downregulated protein expression in primary cHL cases
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Analysis of Pax-5
Pax-5 is a key transcription factor involved in the establishment and maintenance of B cell identity.
Paradoxically Pax-5 is expressed by most HRS cells, but many genes known to be positively regulated by Pax-5 (e.g. CD19, CD21, CD22, CD72, BLNK, CD79a; see Table 1 , Figure 1 
Potential mechanisms for lost B lineage identity in HRS cells
On the basis of the data presented above, we propose that the lack of expression of B lineage-specific genes in 
Loss of the B cell identity in HRS cells: Implications for cHL lymphomagenesis
The loss of tissue-specific markers is a well-known feature of many (mainly progressed) tumors, a process also termed dedifferentiation 50,51 . However, malignant B cells normally express markers and retain complex biological features attributable to specific B cell differentiation stages (see Introduction). It has been suggested that this retained differentiation pattern in B cell NHL relies on an intimate linkage of the transforming event(s) and the differentiation program of the progenitor cell ("differentiation-linked lymphomagenesis") 10,11 . This hypothesis is mainly supported by the fact that most B cell NHL carry translocations of oncogenes into the Ig locus and that the function of these oncogenes is dependent on proper transcriptional activity of the Ig loci.
However, this idea does not hold true for HRS cells, as the B cell phenotype appears not to be essential for, or even incompatible with the pathogenesis of cHL. Hence, one may speculate that the nature of at least one transforming event in cHL must differ fundamentally from those causing other B cell lymphomas.
The present results offer a straightforward explanation for the puzzling finding that the B lineage- 
